We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.01%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$243M
AUM Growth
-$2.1M
(-0.86%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-6.33%
Top 10 Holdings %
Top 10 Hldgs %
78.49%
Holding
71
New
3
Increased
8
Reduced
27
Closed
26
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$701K |
| 2 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$572K |
| 3 |
ALR
Alere Inc
ALR
|
+$290K |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$251K |
| 5 |
Schwab Fundamental US Broad Market Index ETF
FNDB
|
+$230K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ImmunityBio
IBRX
|
+$2.66M |
| 2 |
Becton Dickinson
BDX
|
+$2.16M |
| 3 |
Alexandria Real Estate Equities
ARE
|
+$1.15M |
| 4 |
ResMed
RMD
|
+$1.02M |
| 5 |
Biogen
BIIB
|
+$881K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.95% |
| 2 | Healthcare | 11.05% |
| 3 | Consumer Discretionary | 0% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $957K | 0.39% |
37,966
+5,076
| +15% | +$125K |
2016 Q2
1 quarter
|
|
27
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
| $700K | 0.29% |
30,369
+307
| +1% | +$6.93K |
2015 Q4
3 quarters
|
|
28
Vanguard Energy ETF
VDE
$11.2B
| $605K | 0.25% |
6,198
-110
| -2% | -$10.4K |
2014 Q4
7 quarters
|
|
29
Vanguard FTSE Europe ETF
VGK
$29.7B
| $579K | 0.24% |
11,884
-16,861
| -59% | -$811K |
2013 Q2
13 quarters
|
|
30
iShares MSCI Japan ETF
EWJ
$23.2B
| $552K | 0.23% |
11,024
-6,487
| -37% | -$316K |
2013 Q2
13 quarters
|
|
31
State Street Multi-Asset Real Return ETF
RLY
$1.43B
| $495K | 0.2% |
20,130
| – | – |
2013 Q4
11 quarters
|
|
32
Global X MLP & Energy Infrastructure ETF
MLPX
$3.47B
| $494K | 0.2% |
10,834
| – | – |
2014 Q3
8 quarters
|
|
33
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
| $464K | 0.19% |
11,536
-372
| -3% | -$14.9K |
2013 Q2
13 quarters
|
|
34
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.75B
| $444K | 0.18% |
7,331
-841
| -10% | -$49.2K |
2013 Q2
13 quarters
|
|
35
iShares CMBS ETF
CMBS
$437M
| $420K | 0.17% |
7,910
| – | – |
2013 Q3
12 quarters
|
|
36
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.26B
| $383K | 0.16% |
13,503
| – | – |
2013 Q4
11 quarters
|
|
37
WisdomTree Japan Hedged Equity Fund
DXJ
$2.35B
| $362K | 0.15% |
25,284
-3,492
| -12% | -$48.4K |
2013 Q2
13 quarters
|
|
|
ALR
38
DELISTED
Alere Inc
ALR
| $307K | 0.13% |
+7,100
| New | +$290K |
2016 Q3
0 quarters
|
|
39
iShares MSCI Canada ETF
EWC
$7.28B
| $269K | 0.11% |
10,458
-4,564
| -30% | -$116K |
2013 Q2
13 quarters
|
|
40
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $257K | 0.11% |
6,832
| – | – |
2013 Q2
13 quarters
|
|
|
41
iShares Russell 1000 ETF
IWB
$49.2B
| $252K | 0.1% |
+2,090
| New | +$251K |
2016 Q3
0 quarters
|
|
42
iShares Core S&P 500 ETF
IVV
$889B
| $222K | 0.09% |
1,020
| – | – |
2015 Q4
3 quarters
|
|
43
WisdomTree US LargeCap Dividend Fund
DLN
$6.31B
| $208K | 0.09% |
5,410
-1,462
| -21% | -$56.5K |
2013 Q2
13 quarters
|
|
|
ZSAN
44
DELISTED
Zosano Pharma Corporation
ZSAN
| $13K | 0.01% |
+24
| New | +$19.1K |
2016 Q3
0 quarters
|
|
45
Agios Pharmaceuticals
AGIO
$1.93B
| – | – |
-10,000
| Closed | -$419K | – |
|
|
46
Alexandria Real Estate Equities
ARE
$7.29B
| – | – |
-11,108
| Closed | -$1.15M | – |
|
47
DELISTED
Assertio
ASRT
| – | – |
-178
| Closed | -$210K | – |
|
48
Bank of America
BAC
$362B
| – | – |
-10,009
| Closed | -$133K | – |
|
|
49
Becton Dickinson
BDX
$52.8B
| – | – |
-13,059
| Closed | -$2.16M | – |
|
|
50
Biogen
BIIB
$34.8B
| – | – |
-3,644
| Closed | -$881K | – |
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Callan Capital held 71 positions worth $243M, down 0.86% from $245M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Callan Capital withdrew a net $15.4M in Q3 2016, closing 26 positions and reducing 27 holdings. Its most notable exit was Becton Dickinson, an estimated $2.16M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 86% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Callan Capital opened a new position in Alere Inc worth $307K.
- Callan Capital's largest Q3 2016 buy was Alere Inc: 7,100 shares worth $307K.
- Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q3 2016, an estimated $701K increase.
- Callan Capital's biggest Q3 2016 reduction was ImmunityBio, cutting an estimated $2.66M.
- Callan Capital fully exited Becton Dickinson in Q3 2016, selling an estimated $2.16M.
- Callan Capital's ten largest holdings make up 78% of its $243M portfolio in Q3 2016.
- Callan Capital opened 3 new positions and closed 26 in Q3 2016.
- Callan Capital's portfolio value fell 0.86% quarter-over-quarter to $243M.
Based on Callan Capital's 13F filing for Q3 2016, filed 15 Nov 2016.